DB2115 tertahydrochloride

立即咨询

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

CAS NO:

1366126-19-3

包装与价格：

包装	价格(元)
5mg	电议
10mg	电议
25mg	电议

产品介绍

DB2115 (tertahydrochloride) 是骨髓主调节因子 PU.1 的有效抑制剂。DB2115 (tertahydrochloride) 具有治疗癌症的潜力，包括白血病等血液系统癌症，以及与PU. 1 功能障碍相关的其他疾病 (信息来自专利 WO2017223260A1，compound DB2115)。

Cas No.	1366126-19-3
分子式	C₃₂H₃₄Cl₄N₈O₂
分子量	704.48
溶解度	DMSO : 10 mg/mL (14.19 mM; ultrasonic and warming and adjust pH to 2 with HCl and heat to 80°C)
储存条件	4°C, away from moisture
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
产品描述	DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for the treatment of cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1]. [1]. W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.